PHAXIAM Therapeutics S.A. Euronext Paris
Equities
PHXM
FR0011471135
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 EUR | +1.20% | 0.00% | -35.87% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.80% | 104B | |
+0.99% | 97.42B | |
+1.78% | 22.2B | |
-18.32% | 21.23B | |
-10.88% | 18.33B | |
-42.33% | 16.35B | |
-17.80% | 15.06B | |
+5.37% | 13.98B | |
+27.57% | 11.66B |
- Stock Market
- Equities
- PHXM Stock
- PHXM Stock
- News PHAXIAM Therapeutics S.A.
- Erytech Pharma Says Phase 1 Study of Pancreatic Cancer Drug Showed 'Encouraging' Clinical Activity